Characterization of the T-cell receptor repertoire and immune microenvironment in patients with locoregionally advanced squamous cell carcinoma of the head and neck.

被引：0
|
作者：
Saloura, Vassiliki
Fatima, Aiman
Zewde, Makda
Kiyotani, Kazuma
Brisson, Ryan J.
Park, Jae Hyun
Ikeda, Yuji
Vougiouklakis, Theodore
Bao, Riyue
Seiwert, Tanguy Y.
Cipriani, Nicole
Lingen, Mark W.
Vokes, Everett E.
Nakamura, Yusuke
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3080
引用
收藏
页数：5
相关论文
共 50 条
  • [21] INVESTIGATION OF THE PATHOGENESIS OF T-CELL DYSFUNCTION IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ZIGHELBOIM, J
    HEAD & NECK SURGERY, 1981, 3 (04): : 348 - 349
  • [22] Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma
    Pazhani, Jayanthi
    Jayaraman, Selvaraj
    Veeraraghavan, Vishnu Priya
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (03) : 230 - 231
  • [23] Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
    Mito, Ikko
    Takahashi, Hideyuki
    Kawabata-Iwakawa, Reika
    Ida, Shota
    Tada, Hiroe
    Chikamatsu, Kazuaki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
    Ikko Mito
    Hideyuki Takahashi
    Reika Kawabata-Iwakawa
    Shota Ida
    Hiroe Tada
    Kazuaki Chikamatsu
    Scientific Reports, 11
  • [25] Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma
    Kerrebijn, JD
    Simons, PJ
    Balm, AJM
    Tas, M
    Knegt, PP
    deVries, N
    Tan, IB
    Drexhage, HA
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1996, 18 (04): : 335 - 342
  • [26] Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
    Qi, Xinmeng
    Jia, Bo
    Zhao, Xue
    Yu, Dan
    ONCOTARGETS AND THERAPY, 2017, 10 : 5745 - 5754
  • [27] Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
    Curry, Joseph M.
    Sprandio, John
    Cognetti, David
    Luginbuhl, Adam
    Bar-ad, Voichita
    Pribitkin, Edmund
    Tuluc, Madalina
    SEMINARS IN ONCOLOGY, 2014, 41 (02) : 217 - 234
  • [28] T-CELL ROSETTE TEST IN SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    EASTHAM, RJ
    MASON, JM
    JENNINGS, BR
    BELEW, PW
    MAGUDA, TA
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1976, 102 (03) : 171 - 175
  • [29] Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.
    Even, Caroline
    Martin, Nicolas
    Borcoman, Edith
    Auperin, Anne
    Torossian, Nouritza
    Baste, Neus
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Daste, Amaury
    Saleh, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with squamous cell carcinoma of the head and neck.
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada, Esma
    Even, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345